A popular moisturizer sold at numerous retailers nationwide is being recalled by the Food and Drug Administration, with the FDA giving its second-highest risk-level for those who use the product. The ...
BMO Capital Markets updated its outlook on Travelers Companies Inc (NYSE:TRV), with analyst Michael Zaremski increasing the price target to $297 from the previous $275. The firm has kept an Outperform ...